NEWS

MEA’s Priya Desai, MD, MBA Wins Award

Dr. Desai was recently named one of the “10 Best Corrective Eye Surgeons" in New Jerseyfor 201... | read full article

A Friendly Reminder on Glaucoma

Glaucoma is the leading cause of irreversible blindness worldwide. It is also a silent disease which... | read full article

Could You Have Computer Vision Syndrome?

If you are reading this blog, you likely spend several hours a day looking at digital screens: smart... | read full article

read more news stories

Xiidra™

The FDA recently approved Xiidra™ as a treatment for the signs and symptoms of dry eye disease. It is the first and only prescription eye drop approved for both the signs and symptoms of dry eye disease. This remarkable product is available by prescription only and is now available at all major pharmacies. Matossian Eye Associates was one of the premier clinical trial sites to offer valuable contributions and interest in this important milestone, playing an instrumental role in making this new treatment available for our patients. Owner, Founder, and Chief Medical officer of Matossian Eye Associates and Principal Investigator in the Xiidra™ clinical study Cynthia Matossian, MD, FACS said, “With the epidemic of Dry Eye Disease, we are fortunate to have an additional medicine like Xiidra™ to bring relief to the millions who suffer dry eye symptoms daily.”

Matossian Eye Associates is one of the few practices in the greater area to have samples of Xiidra™ for our patients to try. If you are experiencing stinging or burning eyes, a gritty or scratchy sensation, discomfort in contact lenses, blurred vision, light sensitivity, redness, excessive tearing, and a reliance on artificial tears to get through the day, please call us at 1(800) 708-8800 to schedule a dry eye consult by a fellowship trained, board certified physicians in our Certified Dry Eye Center of Excellence! Please click the video below to hear actress Jennifer Aniston’s experience with dry eye.

 

#EYEPOWERMENT